Sh2,000.00
Albendazol is a medication used for the treatment of a variety of:
| Settings | ALBENDAZOLE SYRP ALBASOL remove | Diclopar gel remove | Vitamin E caps ENAT 400 remove | Apdyl H Syrup remove | Ascoril D syrup remove | Mediven Cream remove |
|---|---|---|---|---|---|---|
| Image |  |  |  |  |  |  |
| SKU | ||||||
| Rating | ||||||
| Price | Sh2,000.00 | Sh3,500.00 | Sh23,000.00 | Sh2,500.00 | Sh3,500.00 | Sh2,500.00 |
| Stock | ||||||
| Availability | ||||||
| Add to cart | ||||||
| Description |
| |||||
| Content | Albendazol is a medication used for the treatment of a variety of:
| Diclopar-Activa is used in the treatment of localised forms of soft-tissue rheumatism (e.g. tendovaginitis, shoulder-hand syndrome, bursitis and periarthropathy), localised rheumatic diseases (e.g. osteo-arthritis of the spine and peripheral joints) and post-traumatic inflammation of the tendons, ligaments, muscles and joints (e.g. due to sprains, strains or bruises). | ENAT 400 is used for the prevention and treatment of vitamin E deficiency. ENAT 400 is used for the prevention and treatment of vitamin E deficiency. | APDYL medication is used to relieve coughs, common cold, bronchitis, and other breathing illnesses. Do not use this product to treat cold symptoms in children younger than 6 years unless specifically directed by the doctor expectorant, cough, cold | Ascoril D Plus Sugar Free Syrup 100 ml belongs to a class of medication called 'cough and cold preparations' primarily used to treat dry cough. Coughing (dry or productive) is the body's way of clearing irritants (like allergens, mucus or smoke) from airways and preventing infection. | Mediven Cream belongs to a group of medicines called steroids. It is used for the treatment of skin disorders such as dermatitis and psoriasis. It relieves swelling, itching, and redness of the skin by suppressing the release of substances that cause inflammation. |
| Weight | ||||||
| Dimensions | N/A | N/A | N/A | N/A | N/A | N/A |
| Additional information |
Reviews
There are no reviews yet.